Gene · 200315
Papers1,983
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,983
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epiregulin is a dendritic cell-derived EGFR ligand that maintains skin and lung fibrosis. | Sci Immunol | 2022 | 36490328 | PubTator, text mining | PubMed |
| Structure-Guided Design of a Potent and Specific Inhibitor against the Genomic Mutator APOBEC3A. | ACS Chem Biol | 2022 | 36475588 | PubTator, text mining | PubMed |
| Evidence linking APOBEC3B genesis and evolution of innate immune antagonism by gamma-herpesvirus ribonucleotide reductases. | Elife | 2022 | 36458685 | PubTator, text mining | PubMed |
| Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response. | NPJ Precis Oncol | 2022 | 36456685 | PubTator, text mining | PubMed |
| Competition for DNA binding between the genome protector replication protein A and the genome modifying APOBEC3 single-stranded DNA deaminases. | Nucleic Acids Res | 2022 | 36444883 | PubTator, text mining | PubMed |
| The coevolution between APOBEC3 and retrotransposons in primates. | Mob DNA | 2022 | 36443831 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of colorectal cancer patients reveals differences in mutational landscapes among clinical and pathological subgroups. | Front Oncol | 2022 | 36439454 | PubTator, text mining | PubMed |
| Expression and regulatory characteristics of peripheral blood immune cells in primary Sjögren's syndrome patients using single-cell transcriptomic. | iScience | 2022 | 36425764 | PubTator, text mining | PubMed |
| Implementation of a combined bioinformatics and experimental approach to address lncRNA mechanism of action: The example of NRIR. | Front Mol Biosci | 2022 | 36406275 | PubTator, text mining | PubMed |
| Activation induced cytidine deaminase: An old friend with new faces. | Front Immunol | 2022 | 36405752 | PubTator, text mining | PubMed |
| Structure of the catalytically active APOBEC3G bound to a DNA oligonucleotide inhibitor reveals tetrahedral geometry of the transition state. | Nat Commun | 2022 | 36402773 | PubTator, text mining | PubMed |
| COVID-19 can lead to rapid progression of cervical intraepithelial neoplasia by dysregulating the immune system: A hypothesis. | J Reprod Immunol | 2022 | 36399874 | PubTator, text mining | PubMed |
| The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer. | Front Immunol | 2022 | 36389711 | PubTator, text mining | PubMed |
| The regulation of antiviral activity of interferon epsilon. | Front Microbiol | 2022 | 36386666 | PubTator, text mining | PubMed |
| Ancestral APOBEC3B Nuclear Localization Is Maintained in Humans and Apes and Altered in Most Other Old World Primate Species. | mSphere | 2022 | 36374108 | PubTator, text mining | PubMed |
| Control of Human Anelloviruses by Cytosine to Uracil Genome Editing. | mSphere | 2022 | 36374042 | PubTator, text mining | PubMed |
| Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma. | EBioMedicine | 2022 | 36371985 | PubTator, text mining | PubMed |
| Acid Catalyzed Stereocontrolled Ferrier-Type Glycosylation Assisted by Perfluorinated Solvent. | Molecules | 2022 | 36364059 | PubTator, text mining | PubMed |
| The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy. | Cancers (Basel) | 2022 | 36358715 | PubTator, text mining | PubMed |
| Early suppression of antiviral host response and protocadherins by SARS-CoV-2 Spike protein in THP-1-derived macrophage-like cells. | Front Immunol | 2022 | 36341352 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200315/papers?page=21